Moving Forward into the New Era of HSCT and Cellular Therapy
Today 2024.10.17 D-End
Today 
Moving Forward into the New Era of HSCT and Cellular Therapy
|
[SA01] Satellite Symposium 1 (Korea Otsuka Pharmaceutical): Treatment of Newly Diagnosed Ph+ ALL September 27 (Fri), 08:30-09:00 |
Room A | |
|---|---|---|
| Chair(s) | Seok Lee (The Catholic University of Korea, Korea) | |
Ponatinib and Chemotherapy for Adult Patients with Newly Diagnosed Ph+ ALL Based from the PhALLCON Trial
Tokai University School of Medicine, Japan
|
[OP05] Oral Presentation 5: AML, MDS, MPN |
Room A | ||
|---|---|---|---|
| Date & Time | September 27 (Fri), 09:00-10:00 | ||
| Chair(s) |
Soo-Mee Bang (Seoul National University College of Medicine, Korea) Sung Hwa Bae (Daegu Catholic University School of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | The Prognostic Impact of Allogeneic Stem Cell Transplantation on Patients with Myelodysplastic Syndromes/Neoplasms Wan-Hsuan Lee (National Taiwan University Hospital, Taiwan) | |
| 09:10-09:20 | Results of Allogeneic Stem Cell Transplantation in Advanced Myelofibrosis Jong Hyuk Lee (The Catholic University of Korea, Korea) | ||
| 09:20-09:30 | Pure Red Cell Aplasia in Acute Myeloid Leukemia Patients after ABO Mismatched HSCT So Yeon Park (The Catholic University of Korea, Korea) | ||
| 09:30-09:40 | Efficacy and Safety of Salvage Chemotherapy Regimens in Relapsed or Refractory Acute Myeloid Leukemia Hun Seok Choi (Yonsei University College of Medicine, Korea) | ||
| 09:40-09:50 | Real World Transplantation Outcomes of Myelofibrosis Treated with Pre-transplant Splenic Irradiation Yu-Sung Chang (National Taiwan University Hospital, Taiwan) | ||
| 09:50-10:00 | Venetoclax/Azacitidine Followed by Allogeneic Transplantation Is as Good as Intensive Chemotherapy Followed by Allogeneic Transplantation for Patients of AML at First Remission Su-Peng Yeh (China Medical University Hospital, Taiwan) | ||
|
[OP06] Oral Presentation 6: Pediatrics |
Room B | ||
|---|---|---|---|
| Date & Time | September 27 (Fri), 09:00-10:00 | ||
| Chair(s) |
Eun Sun Yoo (Ewha Womans University College of Medicine, Korea) Jun Eun Park (Korea University College of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Successful Outcomes of Haploidentical Family Donor Hematopoietic Cell Transplantation in Pediatric Severe Aplastic Anemia Suejung Jo (The Catholic University of Korea, Korea) | |
| 09:10-09:20 | Outcome of Allogenic Hematopoietic Stem Cell Transplantation in Leukodystrophies: A Single-Center Experience over 15 Years Hyun Jin Park (Seoul National University College of Medicine, Korea) | ||
| 09:20-09:30 | Comparable Outcome of Myeloablative Total Body Irradiation Conditioning and Chemo-conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing First Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Korean Registry-Based Study Kyung Taek Hong (Seoul National University College of Medicine, Korea) | ||
| 09:30-09:40 | Feasibility of Tandem Conditioning-Based Myeloablative HSCT for Pediatric Patients with Relapsed/Refractory Myeloid Hematologic Malignancies Jae Won Yoo (The Catholic University of Korea, Korea) | ||
| 09:40-09:50 | Response-Adapted Consolidation Therapy Strategy for Patients with Metastatic High-risk Neuroblastoma: Results of the SMC NB-2014 Study Hee Won Cho (Sungkyunkwan University School of Medicine, Korea) | ||
| 09:50-10:00 | Introduction of Bone Marrow Transplantation in Children in Uzbekistan Khilola Rustamova (Scientific and Practical Center of Pediatric Oncology, Hematology and Immunology of Uzbekistan, Uzbekistan) | ||
|
[OP07] Oral Presentation 7: Basic Research and Others |
Room C | ||
|---|---|---|---|
| Date & Time | September 27 (Fri), 09:00-10:00 | ||
| Chair(s) |
Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea) Yong Park (Korea University College of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Graft-versus-Host Disease Prophylaxis with Post-Transplant Cyclophosphamide Better Preserves Regulatory T Cell Bu-Yeon Heo (Chungnam National University College of Medicine, Korea) | |
| 09:10-09:20 | The Expression of TIM3 on Marrow-Infiltrating T cells Is Increased in Patients with Blood Cancers Who Relapse Early after Hematopoietic Stem Cell Transplantation Thi Thuy Duong Pham (Chungnam National University College of Medicine, Korea) | ||
| 09:20-09:30 | Mesenchymal Stem Cell-Derived Exosomes for Enhanced Proliferation of CD34+ Cells Kunye Kwak (Korea University College of Medicine, Korea) | ||
| 09:30-09:40 | Phase II Trial of Imatinib Mesylate in Patients with Idiopathic Hypereosinophilic Syndrome Dong Hyun Kim (Seoul National University College of Medicine, Korea) | ||
| 09:40-09:50 | Low Dose Fludarabine Is an Effective Conditioning Treatment to Suppress Relapse Rate in PT-CY-Based Haploidentical Peripheral Blood Stem Cell Transplantation Jinhang Kim (The Catholic University of Korea, Korea) | ||
| 09:50-10:00 | Novel Mechanisms of Leukemogenesis: Genome Reorganization by TET Loss of Function Myunggon Ko (Ulsan National Institute of Science and Technology, Korea) | ||
|
[OP08] Oral Presentation 8: Lymphoid Malignancies and CAR-T |
Room D | ||
|---|---|---|---|
| Date & Time | September 27 (Fri), 09:00-10:00 | ||
| Chair(s) |
Seok-Goo Cho (The Catholic University of Korea, Korea) Jeong A Kim (The Catholic University of Korea, Korea) |
||
| Speaker(s) | 09:00-09:10 | Anti-BCMA Dual Epitope-Binding CAR-Marrow Infiltrating Lymphocytes (MILs) against Multiple Myeloma Manh Cuong Vo (Chonnam National University Medical School, Korea) | |
| 09:10-09:20 | CAR-T Therapy in Taiwan: Outcomes and Adverse Events from a National Registry Analysis Xavier Cheng-Hong Tsai (National Taiwan University Hospital, Taiwan) | ||
| 09:20-09:30 | Risk-Stratification for DLBCL Patients Receiving ASCT in the Era of New Targeted Drugs: A Real-World Study in China Wen-Xuan Huo (Peking University People's Hospital, China) | ||
| 09:30-09:40 | Single-cell RNA Analysis of Peripheral T Cells in Chronic Lymphocytic Leukemia Relapse after Chemotherapy or Allogeneic Transplantation Ho Cheol Jang (Chonnam National University Medical School, Korea) | ||
| 09:40-09:50 | Prognostic Factors and Treatment Outcome of Allo-SCT for Lymphoid Malignancy Hyungsoon Kim (Yonsei University College of Medicine, Korea) | ||
| 09:50-10:00 | Efficacy and Safety of Cytokine-Induced Killer Cells Infusion Combined with TRUXIMA as Post-Remission Therapy in Old Aged High-Risk Diffuse Large B Cell Lymphoma Patients Gi June Min (The Catholic University of Korea, Korea) | ||
|
[PL03] Plenary Session 3: New Horizons in the Treatment of Acute Myeloid Leukemia September 27 (Fri), 10:20-11:00 |
Room A | |
|---|---|---|
| Chair(s) | Hyeoung-Joon Kim (Chonnam National University Medical School, Korea) | |
New Horizons in the Treatment of Acute Myeloid Leukemia
The Catholic University of Korea, Korea
|
[PS01] Presidential Symposium: Future Perspectives of HSCT in the Cellular Immunotherapy Era September 27 (Fri), 11:00-11:40 |
Room A | |
|---|---|---|
| Chair(s) | Je-Jung Lee (Chonnam National University Medical School, Korea) | |
Future Perspectives of HSCT in the Cellular Immunotherapy Era
University Medical Center Hamburg-Eppendorf, Germany
|
[LS06] Luncheon Symposium 6 (BMS KOREA): Strategies to Optimize the Outcomes of Transplantation for Myelofibrosis September 27 (Fri), 11:50-12:30 |
Room A | |
|---|---|---|
| Chair(s) | Chul Won Jung (Sungkyunkwan University School of Medicine, Korea) | |
How to Optimize Outcomes of Transplant in Myelofibrosis?
Princess Margaret Cancer Centre, Canada
|
[LS07] Luncheon Symposium 7 (Pfizer Korea): Invasive Mold Infection September 27 (Fri), 11:50-12:30 |
Room B | |
|---|---|---|
| Chair(s) | Hee-Je Kim (The Catholic University of Korea, Korea) | |
Optimal Managing of IMD in the Haematology Unit: Role of Vfend®, Cresemba®
The Catholic University of Korea, Korea
|
[LS08] Luncheon Symposium 8 (Novartis Korea) September 27 (Fri), 11:50-12:30 |
Room C | |
|---|---|---|
| Chair(s) | Je-Hwan Lee (University of Ulsan College of Medicine, Korea) | |
Management of GVHD in 2024 - From Steroid-to-Steroid Sparing Approach
Vanderbilt University Medical Center, USA
|
[LS09] Luncheon Symposium 9 (MSD Korea) September 27 (Fri), 11:50-12:30 |
Room D-1 | |
|---|---|---|
| Chair(s) | Ho-Jin Shin (Pusan National University School of Medicine, Korea) | |
CMV Prophylaxis with Letermovir in Allo HSCT - Extended Use in High Risk Patients
National Cancer Center, Korea
|
[LS10] Luncheon Symposium 10 (Handok Inc.) September 27 (Fri), 11:50-12:30 |
Room D-2 | |
|---|---|---|
| Chair(s) | Jin Seok Kim (Yonsei University College of Medicine, Korea) | |
Remaining Unmet Needs in Current Treatment and a New Treatment Option in PNH
Royal Melbourne Hospital, Australia
|
[SS05] Scientific Session 5: Microbiota in Transplantation and Cell Therapy September 27 (Fri), 12:40-14:10 |
Room A | |
|---|---|---|
| Chair(s) |
Sang Kyun Sohn (Kyungpook National University School of Medicine, Korea) Joon Seong Park (Ajou University School of Medicine, Korea) |
|
Evaluating the Regulatory Mechanisms for the Impact of the Intestinal Microbiome on Chimeric Antigen Receptor T Cells
Stanford University, USA
Prolonged Gut Microbial Alterations in Post-Transplant Survivors of Allogeneic Hematopoietic Stem Cell Transplantation
Osaka University Graduate School of Medicine, Japan
Fecal Microbiota Transplantation in the Prophylactic Setting after Allogeneic Hematopoietic Cell Transplantation
Fred Hutch Cancer Center, USA
|
[SS06] Scientific Session 6: Optimizing Graft Engineering and Cell Therapy September 27 (Fri), 12:40-14:10 |
Room B | |
|---|---|---|
| Chair(s) |
Hyeon Jin Park (National Cancer Center, Korea) Duck Cho (Sungkyunkwan University School of Medicine, Korea) |
|
Haploidentical HCT for Neuroblastoma
University Children’s Hospital Tuebingen, Germany
Graft Engineering and Adoptive Cell Therapy
University of Ulsan College of Medicine, Korea
Modulating NK Cell Synapses for the Improvement of NK Cell Therapy
Department of Materials Science and Engineering, Seoul National University, Korea
|
[ES02] Education Session 2: The Clinical Role of HSCT in Patients with MPN September 27 (Fri), 12:40-14:10 |
Room C | |
|---|---|---|
| Chair(s) |
Chul Won Choi (Korea University Guro Hospital, Korea) Sung-Yong Kim (Konkuk University School of Medicine, Korea) |
|
Considerations before HSCT for Patients with MF
The Catholic University of Korea, Korea
Considerations About HSCT for Patients with MF (Donor, Conditioning Regimen, Engraftment, GVHD Prophylaxis)
Seoul National University College of Medicine, Korea
Is HSCT Still the Effective Treatment for CML?
Soonchunhyang University College of Medicine, Korea
|
[SS07] Scientific Session 7: Innovations in Cellular Therapy and Beyond September 27 (Fri), 12:40-14:10 |
Room D | |
|---|---|---|
| Chair(s) |
Chang-Ki Min (The Catholic University of Korea, Korea) Hyeon-Seok Eom (National Cancer Center, Korea) |
|
Next-Generation Novel Therapies in Multiple Myeloma
Dana-Farber Cancer Institute, USA
CAR-19 Expressing Regulatory T cells to Enhance GVHD-free, Relapse-free Survival in Patients with High Risk CD19+ Hematological Malignancy: Rationale and Developmental Pathway
University of Minnesota, USA
CAR-T Cell Therapy in Gastrointestinal Cancers
Peking University Cancer Hospital & Institute, China
|
[JS03] Joint Symposium 3: EBMT-KSBMT: Disease-specific Issues and Transplantation Outcomes of CBT and HIDT September 27 (Fri), 14:20-16:00 |
Room A | |
|---|---|---|
| Chair(s) |
Seong Kyu Park (Soonchunhyang University College of Medicine, Korea) Anna Sureda (Catalan Institute of Oncology, Spain) |
|
Current Status of Alternative Donor Transplantation Compared to Conventional Donor: EBMT Perspectives
IRCCS San Raffaele Hospital, Italy
KIR-Mismatch and Transplantation Outcome in Myeloid vs. Lymphoid Disease
Chaim Sheba Medical Center, Israel
Outcome of Alternative Donor Transplantation in AML and MDS in Korea
Chonnam National University Medical School, Korea
Alternative Donor Hematopoietic Cell Transplantation (HCT): Korean Experiences and Optimization of Cord Blood and Haploidentical Donor HCT in Adult ALL
The Catholic University of Korea, Korea
|
[DS01] Debate Session 1: ASCT for Multiple Myeloma Patients with Chronic Kidney Disease September 27 (Fri), 14:20-16:00KorKorean-English |
Room B | |
|---|---|---|
| Chair(s) | Jin Seok Kim (Yonsei University College of Medicine, Korea) | |
No Upfront ASCT
Dong-A University College of Medicine, Korea
Upfront ASCT
Chungnam National University College of Medicine, Korea
|
[DS02] Debate Session 2: Upfront HSCT for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Children and Adolescents September 27 (Fri), 14:20-16:00KorKorean-English |
Room B | |
|---|---|---|
| Chair(s) | Kyung-Nam Koh (University of Ulsan College of Medicine, Korea) | |
Cons: Upfront HSCT Is Not Needed
Sungkyunkwan University School of Medicine, Korea
Pro: Upfront HSCT Is Needed
Yonsei University College of Medicine, Korea
|
[ES03] Education Session 3: Post-HSCT, Non-hematological Complication and Management September 27 (Fri), 14:20-15:50 |
Room C | |
|---|---|---|
| Chair(s) |
Jae-Yong Kwak (Jeonbuk National University Medical School, Korea) Hyoung Soo Choi (Seoul National University College of Medicine, Korea) |
|
Late Effect of Transplantation
Fujita Health University School of Medicine, Japan
Post-HSCT Psychological Impact and Care
Department of Psychiatry, Seoul National University College of Medicine, Korea
Fertility after Allogeneic Hematopoietic Stem Cell Transplantation
University of Ulsan College of Medicine, Korea
|
[SS08] Scientific Session 8: The 30th Anniversary Symposium of KMDP & CHSCB September 27 (Fri), 14:20-16:05 |
Room D | |
|---|---|---|
| Chair(s) |
Hong Ghi Lee (Konkuk University Medical Center, Korea) Yeun Jun Chung (The Catholic University of Korea, Korea) |
|
Opening Remark
Konkuk University Medical Center, Korea
Transplants from Unrelated Donors in the United States: Where We Are, Where We Are Going
Fred Hutch Cancer Center, USA
Transplants from Unrelated Donors in Europe: Where We Are and Where We Are Going
University Medical Center Hamburg-Eppendorf, Germany
Designing the Future of Unrelated Donor Registries and Transplantation - JMDP Perspective -
Keio University School of Medicine, Japan
Unrelated Donor Hematopoietic Stem Cell Transplantation in Korea
Sungkyunkwan University School of Medicine, Korea
Closing Remark
The Catholic University of Korea, Korea
|
[JS04] Joint Symposium 4: East Asia Collaborative Session: Autologous Transplantation Strategies for High-risk Myeloma in the East-Asian Countries September 27 (Fri), 16:30-18:10 |
Room A | |
|---|---|---|
| Chair(s) |
Je-Jung Lee (Chonnam National University Medical School, Korea) Chi-Cheng Li (Hualien Tzu Chi Hospital, Taiwan) |
|
Current Role of ASCT in Multiple Myeloma
Chonnam National University Medical School, Korea
Autologous Stem Cell Mobilization and Transplantation for Multiple Myeloma - Current Status and Future Perspectives in Japan -
Japanese Red Cross Medical Center, Japan
Current Status of ASCT and the Role of CAR-T Cell Therapy in Managing Myeloma in China
Peking University People's Hospital, China
Post-Transplant Maintenance Therapy in Patients with Multiple Myeloma in Taiwan
National Taiwan University Hospital, Taiwan
|
[SS09] Scientific Session 9: Advancements in AML and MDS September 27 (Fri), 16:40-18:10 |
Room B | |
|---|---|---|
| Chair(s) |
Yoo Hong Min (Yonsei University School of Medicine, Korea) Kyoo-Hyung Lee (Ewha Womans University College of Medicine, Korea) |
|
Base Editing of Surface Epitopes to Empower Cancer Immunotherapy and Beyond
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, USA
Is AML Remission Induction Prior to alloHCT Necessary?
University Hospital Carl Gustav Carus Dresden, Germany
Salvage HSCT in AML: Strategies for Improvement
Seoul National University College of Medicine, Korea
|
[SS10] Scientific Session 10: Regulatory Status of Novel Cell and Gene Therapy September 27 (Fri), 16:40-18:10 |
Room C | |
|---|---|---|
| Chair(s) |
Hyoung Jin Kang (Seoul National University College of Medicine, Korea) So Ra Park (Regenerative Medicine Acceleration Foundation, Korea) |
|
Regulatory Science Updates for Advanced Biological Products in Korea
Cell&Gene Therapy Products Division/MFDS, Korea
Opportunities and Challenges on Clinical Translation of Cell & Gene Therapy in Korea
Regenerative Medicine Acceleration Foundation, Korea
From Lab to Bedside: Navigating FDA Regulations for Novel Cell Therapies in the US
Children's Hospital Colorado, USA
|
[ES04] Education Session 4: Back to the Basic - Guidelines of Hematopoietic Stem Cell Transplantation September 27 (Fri), 16:40-18:10 |
Room D | |
|---|---|---|
| Chair(s) |
Sung-Hyun Kim (Dong-A University College of Medicine, Korea) Jung Woo Han (Yonsei University College of Medicine, Korea) |
|
Vaccination Guidelines after Hematopoietic Cell Transplantation
Chonnam National University Medical School, Korea
Cytomegalovirus in Hematopoietic Cell Transplantation: Prophylaxis & Treatment
The Catholic University of Korea, Korea
Appropriate Screening for cGVHD
Kyungpook National University School of Medicine, Korea
& Voting will be provided.